Stuart Walter Peltz

Stuart Walter Peltz is a declared insider of PTC Therapeutics, Inc. (chief executive), with filings sourced from SEC (Form 4). The record holds 193 filings, for trades running from 7 March 2014 to 31 January 2023.

On the market, this insider has only sold: 140 sales, €76.0M in total. Outside the open market, there are 12 share grants and 41 option exercises. So far in 2023, the count stands at no purchases and 9 sales.

On 2 February 2023 came the latest disclosure, an open-market sale for €13k in PTC Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.